Physician profile

Angela L Roberts

Family Medicine · Youngstown, OH

NPI 1194833509

$6,508.59

in general payments reported to CMS, 2019-2025

41 companies · $110 in 2025

The $110 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

See the full distribution for Family Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,182.55

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,446.53 2021-2025 Vraylar, Ubrelvy, Qulipta
Novo Nordisk INC $785.77 2019-2024 Rybelsus, Ozempic
Astrazeneca Pharmaceuticals LP $757.34 2019-2025 Airsupra, Farxiga, Breztri
Amarin Pharma, INC. $585.04 2019-2023
Amgen INC. $496.97 2019-2024 Repatha, Otezla
Lilly USA, LLC $417.15 2019-2024 Mounjaro, Jardiance, Emgality
Pfizer INC. $355.65 2019-2024
Bayer Healthcare Pharmaceuticals INC. $248.25 2019-2023
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $188.02 2019-2024 Trulance, Xifaxan
Biohaven Pharmaceutical Holding Company LTD. $137.57 2022
Exact Sciences Corporation $95.05 2023 Cologuard Collection Kit
Abbott Laboratories $83.92 2022-2024 Freestyle Libre 3
Takeda Pharmaceuticals U.S.A., INC. $79.10 2019-2022
Novartis Pharmaceuticals Corporation $78.83 2021-2023
Boehringer Ingelheim Pharmaceuticals, INC. $73.48 2019-2022
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $67.43 2019-2021
Glaxosmithkline, LLC. $66.30 2022-2024 Trelegy Ellipta, Shingrix
Daiichi Sankyo INC. $44.29 2020-2023 Injectafer
Corium, LLC $42.03 2022-2023 Azstarys
Sunovion Pharmaceuticals INC. $41.50 2022
Ibsa Pharma INC. $35.42 2023 Tirosint, Licart
Otsuka America Pharmaceutical, INC. $34.65 2024 Rexulti
Biohaven Pharmaceuticals, INC. $32.99 2021
Nestle Healthcare Nutrition INC. $30.45 2022
Astellas Pharma US INC $29.61 2020
Allergan, INC. $26.83 2019
Nevro Corp. $22.91 2021
Genentech USA, INC. $22.73 2019
Currax Pharmaceuticals LLC $17.28 2021
Teva Pharmaceuticals USA, INC. $17.23 2020
E.R. Squibb & Sons, L.L.C. $17.10 2024 Camzyos
Horizon Therapeutics Plc $16.47 2022
Shield Therapeutics INC $16.31 2023 Accrufer
Janssen Pharmaceuticals, INC $15.53 2022
Avanir Pharmaceuticals, INC. $15.36 2019
Ultragenyx Pharmaceutical INC. $14.07 2021
Sanofi-Aventis U.S. LLC $12.94 2021
Esperion Therapeutics, INC. $11.82 2021
Almatica Pharma LLC $11.76 2021
Sumitomo Pharma America, INC. $10.78 2023 Gemtesa
Phathom Pharmaceuticals, INC. $6.13 2025 Voquezna

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Angela L Roberts

$6,508.59

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $110 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/144766/angela-l-roberts

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.